Exercise Capacity and Physical Activity Level in Prolactinoma Patients
NCT05236829 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38
Last updated 2024-05-24
Summary
Prolactinoma, one of the most common pituitary adenomas, is an adenoma that causes excessive prolactin (PRL) secretion. An increase in prolactin level can cause weakness, decrease in muscle mass and fatigue. It is not known in detail to what extent it affects quality of life, functional exercise capacity, cardiovascular disease risk factors, physical activity level, fatigue and sleep quality in prolactinoma patients. It is aimed to compare how much exercise capacity, physical activity level, sleep quality, perception of fatigue and quality of life of prolactinoma patients are affected compared to healthy individuals and to examine the factors associated with exercise capacity in prolactinoma patients.
Conditions
- Prolactinoma
Sponsors & Collaborators
-
Hacettepe University
lead OTHER
Principal Investigators
-
Ebru Calik Kutukcu, PhD · Hacettepe University
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-06-16
- Primary Completion
- 2022-10-15
- Completion
- 2022-10-15
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Cardiac and Skeletal Muscle Energy Metabolism in Abnormal Growth Hormone States
NCT00461240 ·Status: COMPLETED
-
Quality of Life and Psychosocial Dimension in Children With Hypopituitarism
NCT05403255 ·Status: UNKNOWN
-
The Observational Study of Growth Hormone-secreting Pituitary Tumors
NCT01368133 ·Status: UNKNOWN
-
Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas
NCT03400865 ·Status: UNKNOWN ·Phase: NA
-
Pituitary Adenoma and Serum Lipid
NCT04021212 ·Status: UNKNOWN
-
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
NCT00001595 ·Status: RECRUITING
-
Prospective Quality of Life Study in Pituitary Surgery
NCT03694990 ·Status: UNKNOWN
-
Muscle in Acromegaly and Cushing's Syndrome
NCT03673761 ·Status: UNKNOWN
-
Growth Hormone Use in Adults With Prader-Willi Syndrome
NCT00444964 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Characteristics and Analysis of Pituitary Complex and Rare Diseases
NCT06435195 ·Status: RECRUITING
-
Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly
NCT00921609 ·Status: COMPLETED
-
GH in Adults With PWS, Effect on Hypotonia Evaluated by Functional MRI, Relationship With Strength and Body Composition
NCT03616509 ·Status: COMPLETED ·Phase: PHASE4
-
Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools
NCT01775332 ·Status: UNKNOWN ·Phase: NA
-
Alterations of Muscle Secretome Associated With Muscle Atrophy Caused by Glucocorticoids
NCT03229395 ·Status: COMPLETED
-
Assessment of Changes in Metabolic Activity in Liver & Skeletal Muscle in Patients Suffering From Acromegaly
NCT02115906 ·Status: UNKNOWN
-
Study on Therapy of Non-invasive Prolactinoma
NCT03353025 ·Status: RECRUITING ·Phase: NA
-
Prospective Study on Changes in Acromegaly
NCT01612624 ·Status: UNKNOWN
-
Effects of Growth Hormone in Chronically Ill Children
NCT00286689 ·Status: WITHDRAWN ·Phase: NA
-
Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas
NCT01620138 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
An Assessment of the Occurrence of Hormone Deficiency in Patients With Empty Sella
NCT04700020 ·Status: UNKNOWN ·Phase: NA
-
Detailed Clinical, Biochemical and Genetic Characterization in Gonadotropin-releasing Hormone (GnRH) Deficiency Disorders
NCT01165619 ·Status: TERMINATED
-
Acromegaly Treatment Quality of Life Study
NCT01732406 ·Status: COMPLETED
-
Setting Benchmarks for Transsphenoidal Resection of Pituitary Adenomas
NCT04951557 ·Status: UNKNOWN
-
Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly
NCT00004332 ·Status: COMPLETED
-
KETOgenic Diet Therapy in Patients With ACROmegaly
NCT06949891 ·Status: RECRUITING ·Phase: NA